Related references
Note: Only part of the references are listed.Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality A Cohort Study
Marc R. Larochelle et al.
ANNALS OF INTERNAL MEDICINE (2018)
Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence
Roxanne Saucier et al.
DRUG SAFETY (2018)
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
Joshua D. Lee et al.
LANCET (2018)
Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone
Edward V. Nunes et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2018)
Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone
Erin Kelty et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2017)
Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England
John Marsden et al.
ADDICTION (2017)
The toxicology of heroin-related death: estimating survival times
Shane Darke et al.
ADDICTION (2016)
Years of potential life lost amongst heroin users in the Australian Treatment Outcome Study cohort, 2001-2015
Shane Darke et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone
Maria A. Sullivan et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Excess mortality among opioid-using patients treated with oral naltrexone in Australia
Louisa Degenhardt et al.
DRUG AND ALCOHOL REVIEW (2015)
Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: A very low dose naltrexone and buprenorphine open label trial
Paolo Mannelli et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
Phase I Study of Injectable, Depot Naltrexone for the Relapse Prevention Treatment of Opioid Dependence
Wang Xuyi et al.
AMERICAN JOURNAL ON ADDICTIONS (2014)
A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence
Sarah Larney et al.
DRUG AND ALCOHOL REVIEW (2014)
Mortality After Prison Release: Opioid Overdose and Other Causes of Death, Risk Factors, and Time Trends From 1999 to 2009
Ingrid A. Binswanger et al.
ANNALS OF INTERNAL MEDICINE (2013)
Naltrexone Level and Biochemical Profile of Opiate-dependent Patients on Naltrexone Maintenance Program: A Pilot Study
Rizwana Quraishi et al.
ADDICTIVE DISORDERS & THEIR TREATMENT (2013)
Examination of mortality rates in a retrospective cohort of patients treated with oral or implant naltrexone for problematic opiate use
Erin Kelty et al.
ADDICTION (2012)
Naltrexone Depot Formulations for Opioid and Alcohol Dependence: A Systematic Review
Philipp P. Lobmaier et al.
CNS NEUROSCIENCE & THERAPEUTICS (2011)
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
Evgeny Krupitsky et al.
LANCET (2011)
Injectable extended-release naltrexone for opioid dependence
Evgeny Krupitsky et al.
LANCET (2011)
Naltrexone Implants Compared to Methadone: Outcomes Six Months after Prison Release
Philipp P. Lobmaier et al.
EUROPEAN ADDICTION RESEARCH (2010)
An automated, highly sensitive LC-MS/MS assay for the quantification of the opiate antagonist naltrexone and its major metabolite 6β-naltrexol in dog and human plasma
Claudia Clavijo et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment
Robert James Tait et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2008)
Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records
Amy E. Gibson et al.
DRUG AND ALCOHOL REVIEW (2007)
Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants
GK Hulse et al.
DRUG AND ALCOHOL DEPENDENCE (2005)
Fatal opiate overdose following regimen changes in naltrexone treatment
P Oliver et al.
ADDICTION (2005)
Determination of naltrexone and 6-β-naltrexol in human plasma following implantation of naltrexone pellets using gas chromatography mass spectrometry
SW Toennes et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2004)
Blood naltrexone and 6-β-naltrexol levels following naltrexone implant:: comparing two naltrexone implants
GK Hulse et al.
ADDICTION BIOLOGY (2004)
Naltrexone maintenance for heroin dependence: uptake, attrition and retention
TK Tucker et al.
DRUG AND ALCOHOL REVIEW (2004)
Blood morphine levels in naltrexone-exposed compared to non-naltrexone-exposed fatal heroin overdoses
DE Arnold-Reed et al.
ADDICTION BIOLOGY (2003)
A pilot study to assess the impact of naltrexone implant on accidental opiate overdose in 'high-risk' adolescent heroin users
GK Hulse et al.
ADDICTION BIOLOGY (2003)
Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study
J Strang et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Behavioral naltrexone therapy: an integrated treatment for opiate dependence
JL Rothenberg et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2002)
Share Paper
